141 related articles for article (PubMed ID: 33035625)
1. Anti-inflammatory effect of IGF-1 is mediated by IGF-1R cross talk with GPER in MPTP/MPP
Yuan LJ; Zhang M; Chen S; Chen WF
Mol Cell Endocrinol; 2021 Jan; 519():111053. PubMed ID: 33035625
[TBL] [Abstract][Full Text] [Related]
2. G protein-coupled estrogen receptor is involved in the neuroprotective effect of IGF-1 against MPTP/MPP
Yuan LJ; Wang XW; Wang HT; Zhang M; Sun JW; Chen WF
J Steroid Biochem Mol Biol; 2019 Sep; 192():105384. PubMed ID: 31175966
[TBL] [Abstract][Full Text] [Related]
3. IGF-1 inhibits MPTP/MPP
Wang XW; Yuan LJ; Yang Y; Zhang M; Chen WF
Am J Physiol Endocrinol Metab; 2020 Oct; 319(4):E734-E743. PubMed ID: 32865008
[TBL] [Abstract][Full Text] [Related]
4. GPER and IGF-1R mediate the anti-inflammatory effect of genistein against lipopolysaccharide (LPS)-induced nigrostriatal injury in rats.
Du ZR; Gu Y; Xie XM; Zhang M; Jiang GY; Chen WF
J Steroid Biochem Mol Biol; 2021 Nov; 214():105989. PubMed ID: 34478828
[TBL] [Abstract][Full Text] [Related]
5. G protein-coupled estrogen receptor is involved in the anti-inflammatory effects of genistein in microglia.
Du ZR; Feng XQ; Li N; Qu JX; Feng L; Chen L; Chen WF
Phytomedicine; 2018 Apr; 43():11-20. PubMed ID: 29747742
[TBL] [Abstract][Full Text] [Related]
6. Involvement of IGF-1 receptor signaling pathway in the neuroprotective effects of Icaritin against MPP(+)-induced toxicity in MES23.5 cells.
Jiang MC; Chen XH; Zhao X; Zhang XJ; Chen WF
Eur J Pharmacol; 2016 Sep; 786():53-59. PubMed ID: 27238975
[TBL] [Abstract][Full Text] [Related]
7. IGF-1 receptor is involved in the regulatory effects of icariin and icaritin in astrocytes under basal conditions and after an inflammatory challenge.
Zhang WD; Li N; Du ZR; Zhang M; Chen S; Chen WF
Eur J Pharmacol; 2021 Sep; 906():174269. PubMed ID: 34147477
[TBL] [Abstract][Full Text] [Related]
8. MiR-302b-5p enhances the neuroprotective effect of IGF-1 in methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease by regulating inducible nitric-oxide synthase.
Cui X; Li M; He Z; Hu L; Liu J; Yan J; Hua L
Cell Biochem Funct; 2020 Dec; 38(8):1025-1035. PubMed ID: 32474958
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-β1 acts via TβR-I on microglia to protect against MPP(+)-induced dopaminergic neuronal loss.
Liu Z; Chen HQ; Huang Y; Qiu YH; Peng YP
Brain Behav Immun; 2016 Jan; 51():131-143. PubMed ID: 26254549
[TBL] [Abstract][Full Text] [Related]
10. GPER1-mediated immunomodulation and neuroprotection in the myenteric plexus of a mouse model of Parkinson's disease.
Côté M; Bourque M; Poirier AA; Aubé B; Morissette M; Di Paolo T; Soulet D
Neurobiol Dis; 2015 Oct; 82():99-113. PubMed ID: 26051538
[TBL] [Abstract][Full Text] [Related]
11. Shikonin ameliorates oxidative stress and neuroinflammation via the Akt/ERK/JNK/NF-κB signalling pathways in a model of Parkinson's disease.
Guo L; Li Y; Li W; Qiu J; Du J; Wang L; Zhang T
Clin Exp Pharmacol Physiol; 2022 Nov; 49(11):1221-1231. PubMed ID: 36054693
[TBL] [Abstract][Full Text] [Related]
12. GPER activation is effective in protecting against inflammation-induced nigral dopaminergic loss and motor function impairment.
Mendes-Oliveira J; Lopes Campos F; Videira RA; Baltazar G
Brain Behav Immun; 2017 Aug; 64():296-307. PubMed ID: 28450223
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of neuroinflammatory responses and behavioral deficits by Ligusticum officinale (Makino) Kitag in stimulated microglia and MPTP-induced mouse model of Parkinson's disease.
Kim BW; Koppula S; Park SY; Kim YS; Park PJ; Lim JH; Kim IS; Choi DK
J Ethnopharmacol; 2015 Apr; 164():388-97. PubMed ID: 25449453
[TBL] [Abstract][Full Text] [Related]
14. A Mouse Model of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Induced Parkinson Disease Shows that 2-Aminoquinoline Targets JNK Phosphorylation.
Zhu M; Gong D
Med Sci Monit; 2020 Apr; 26():e920989. PubMed ID: 32333598
[TBL] [Abstract][Full Text] [Related]
15. [P38 MAPK signaling pathway regulates nuclear factor-κB and inducible nitric oxide synthase expressions in the substantia nigra in a mouse model of Parkinson's disease].
Wang Q; Zhang H; Liu M; Zhang Z; Wei Z; Sun N; Mao T; Zhang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jul; 34(8):1176-80. PubMed ID: 25176090
[TBL] [Abstract][Full Text] [Related]
16. Alteration of nuclear factor-kappaB pathway promote neuroinflammation depending on the functions of estrogen receptors in substantia nigra after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
Mitra S; Ghosh N; Sinha P; Chakrabarti N; Bhattacharyya A
Neurosci Lett; 2016 Mar; 616():86-92. PubMed ID: 26827723
[TBL] [Abstract][Full Text] [Related]
17. Febuxostat Inhibits MPP+-Induced Inflammatory Response Through Inhibiting the JNK/NF-κB Pathway in Astrocytes.
Yan W; Zhang Y; Hu L; Li Q; Zhou H
Neurotox Res; 2021 Jun; 39(3):566-574. PubMed ID: 33443645
[TBL] [Abstract][Full Text] [Related]
18. The novel protective effects of loganin against 1-methyl-4-phenylpyridinium-induced neurotoxicity: Enhancement of neurotrophic signaling, activation of IGF-1R/GLP-1R, and inhibition of RhoA/ROCK pathway.
Tseng YT; Lin WJ; Chang WH; Lo YC
Phytother Res; 2019 Mar; 33(3):690-701. PubMed ID: 30556245
[TBL] [Abstract][Full Text] [Related]
19. Epimedin B exerts neuroprotective effect against MPTP-induced mouse model of Parkinson's disease: GPER as a potential target.
Zhang M; Hu ZF; Dong XL; Chen WF
Biomed Pharmacother; 2022 Dec; 156():113955. PubMed ID: 36411637
[TBL] [Abstract][Full Text] [Related]
20. Bear bile powder alleviates Parkinson's disease-like behavior in mice by inhibiting astrocyte-mediated neuroinflammation.
Wang L; Bai Y; Tao Y; Shen W; Zhou H; He Y; Wu H; Huang F; Shi H; Wu X
Chin J Nat Med; 2023 Sep; 21(9):710-720. PubMed ID: 37777320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
